Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
TGFβ signaling enacts tumor-suppressive functions in normal cells through promotion of several cell regulatory actions including cell-cycle control and apoptosis. Canonical TGFβ signaling proceeds through phosphorylation of the transcription factor, SMAD3, at the C-terminus of the protein. During on...
Saved in:
Main Authors: | Joseph T. Decker, Jeffrey A. Ma, Lonnie D. Shea, Jacqueline S. Jeruss |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/201ed25b35bb465cbe9f3da4b58fbc5f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
by: Wang Jian, et al.
Published: (2020) -
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
by: Emily Jiggens, et al.
Published: (2021) -
Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
by: Wang,Yanqiu, et al.
Published: (2018) -
SP-1154, a novel synthetic TGF-β inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice
by: Kisoo Pahk, et al.
Published: (2022) -
Sinomenine Relieves Airway Remodeling By Inhibiting Epithelial-Mesenchymal Transition Through Downregulating TGF-β1 and Smad3 Expression In Vitro and In Vivo
by: Hongjuan He, et al.
Published: (2021)